ZVRA Stock Summary and Trading Ideas (Zevra Therapeutics | NASDAQ:ZVRA)

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Zevra Therapeutics trades on the NASDAQ stock market under the symbol ZVRA.

As of March 4, 2025, ZVRA stock price declined to $7.29 with 125,525 million shares trading.

ZVRA has a beta of 1.21, meaning it tends to be more sensitive to market movements. ZVRA has a correlation of 0.07 to the broad based SPY ETF.

ZVRA has a market cap of $389.11 million. This is considered a Small Cap stock.

Last quarter Zevra Therapeutics reported $4 million in Revenue and -$.69 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.27.

The top ETF exchange traded funds that ZVRA belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWO.

ZVRA has underperformed the market in the last year with a price return of +3.0% while the SPY ETF gained +13.2%. ZVRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.4% and -9.7%, respectively, while the SPY returned -4.7% and -5.9%, respectively.

ZVRA support price is $7.07 and resistance is $7.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZVRA shares will trade within this expected range on the day.